SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen
9 references·1 citing·37 second hop
Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen (2019)Progesterone Is Important for Transgender…Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons (2018)Cross-sex Hormones and Acute …Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline (2017)Endocrine Treatment of Gender…Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy (2017)Cardiovascular Disease Among …Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study (2017)Breast Development in Transwo…Oestrogen and anti-androgen therapy for transgender women (2016)Oestrogen and anti-androgen t…Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data (2016)Cross-Sex Hormone Treatment a…Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones (2014)Clinical Review: Breast Devel…Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons (2012)Long-Term Evaluation of Cross…Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism (1989)Spironolactone with physiolog…MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people (2021)MANAGEMENT OF ENDOCRINE DISEA…Mortality and morbidity in transsexual subjects treated with cross‐sex hormones (1997)Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline (2009)A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones (2011)Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study (2013)Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence (2014)Endocrinology of Transgender Medicine (2018)Sexual and Physical Health After Sex Reassignment Surgery (2005)Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 (2012)Trans* Pregnancy and Lactation: A Literature Review from a Nursing Perspective (2019)European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, with Attention for Sexual Function and Satisfaction” (2020)TRANSSEXUALISM AND SEX REASSIGNMENT (1970)Endocrine Therapy of Transsexualism and Potential Complications of Long-Term Treatment (1998)Endocrine intervention for transsexuals (2003)Diagnostic and Statistical Manual of Mental Disorders(DSM) (2008)Hormonal therapy and sex reassignment: a systematic review and meta‐analysis of quality of life and psychosocial outcomes (2009)Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study (2018)Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition (2018)Understanding the Impact of the COVID-19 Pandemic on the Mental Health of Transgender and Gender Nonbinary Individuals Engaged in a Longitudinal Cohort Study (2021)Barriers to healthcare for transgender individuals (2016)Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people (2017)Gender-affirming hormones and surgery in transgender children and adolescents (2018)The Perioperative Care of the Transgender Patient (2018)Minority Stress and Mental Health in Gay Men (1995)Measuring multiple minority stress: The LGBT People of Color Microaggressions Scale. (2011)Global health burden and needs of transgender populations: a review (2016)Sociodemographic and Clinical Characteristics of Transgender Adults in Australia (2018)Health and Health Care Among Transgender Adults in the United States (2021)Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria (2021)Mortality and morbidity in transsexual patients with cross-gender hormone treatment (1989)Gender affirming medical care of transgender youth (2019)Position statement on the hormonal management of adult transgender and gender diverse individuals (2019)Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands (2019)Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents (2018)Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation (2020)Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population (2019)Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association (2020)Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association (2021)
this work references cited by second hop

References

  • 2017Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline2,326 cited
  • 2018Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons430 cited
  • 2012Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons336 cited
  • 2016Oestrogen and anti-androgen therapy for transgender women208 cited
  • 2017Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy205 cited
  • 2016Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data200 cited
  • 2014Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones126 cited
  • 1989Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism109 cited
  • 2017Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study95 cited

Cited by

  • 2021MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people66 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work